Fig. 2.
Schematic diagram outlining the major parameters affecting the severity of liver fibrosis and the major points at which potential anti-fibrogenic therapeutics intervene. Numbers refer to numbering for “mode of action” as given in Table 1. Inhibition, T; promoters, ↑